Domov › Rak jajčnikov › Kalifornija

Klinične študije za Rak jajčnikov v Kalifornija

105 študij za Rak jajčnikov išče udeležence na lokacijah v Kalifornija.

Mesta v Kalifornija

Uradno besedilo študije (angleško)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

PCR Oncology, Arroyo Grande
Mercy Cancer Center - Carmichael, Carmichael
Mercy San Juan Medical Center, Carmichael
in še 15

Vključevanje udeležencevFaza 2

Vse starosti · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of San Diego Moores Cancer Center, La Jolla
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
in še 10

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07059884

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

City of Hope National Medical Center, Duarte
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
UCLA Department of Medicine-Hematology/Oncology, Los Angeles

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06465069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

City of Hope - Duarte Cancer Center, Duarte

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06760819

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

University of California - Los Angeles, Los Angeles

Vključevanje udeležencevFaza 1

Starost 19 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06586957

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Start Los Angeles /ID# 281533, Los Angeles

Vključevanje udeležencevFaza 2

Starost 18 in več · Ženske · Posodobljeno 1. okt. 2026 · NCT07024784

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

City of Hope National Medical Center /ID# 281381, Duarte
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 280914, Irvine

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07278336

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Duarte
Research Site, Los Angeles
Research Site, Newport Beach
in še 1

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT05877599

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

UCLA - University of California Los Angeles Medical Center /ID# 274566, Los Angeles
Scripps Md Anderson - Prebys Cancer Center /ID# 276891, San Diego
California Pacific Medical Center - Van Ness Campus /ID# 275329, San Francisco

Vključevanje udeležencevFaza 2

Starost 18 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT06890338

DESTINY-PANTUMOUR04

Research Site, San Diego

Vključevanje udeležencevOpazovalna študija

Starost 18–130 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

University of California San Diego, La Jolla
Stanford University, Palo Alto
UCLA Medical Center, Santa Monica

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT04981119

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

City of Hope Comprehensive Cancer Center, Duarte
The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Chao Family Comprehensive Cancer Center, Orange

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Ženske · Posodobljeno 24. sep. 2026 · NCT04590326

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, Santa Monica

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07229313

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Los Angeles
Research Site, Santa Rosa

Vključevanje udeležencevFaza 2

Starost 18–130 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

UC IRVINE Health, Orange
UC Davis Comprehensive Cancer Center, Sacramento
Stanford Cancer Institute, Stanford

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06128551

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

UC San Diego Health - Moores Cancer Center /ID# 277574, La Jolla

Vključevanje udeležencevFaza 2

Starost 18 in več · Ženske · Posodobljeno 22. sep. 2026 · NCT07059845

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center, Burbank
City of Hope, Duarte, Duarte
City of Hope Lennar, Irvine
in še 6

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Hoag Memorial Hospital Presbyterian, Newport Beach
Stanford University Medical Center, Stanford

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213791

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Beverly Hills Cancer Center, Beverly Hills
City of Hope Cancer Center, Duarte
University of California Irvine Medical Center, Orange
in še 1

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05983432

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

City of Hope National Medical Center, Duarte

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT04752826

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

City of Hope, Duarte
City of Hope, Irvine, Irvine

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07109726

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

John Muir Health Cancer Center ( Site 0069), Walnut Creek

Vključevanje udeležencevFaza 3

Starost 18 in več · Ženske · Posodobljeno 17. sep. 2026 · NCT07318558

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

University of California, Los Angeles Medical Center, Los Angeles
Scripps Healthscripps Mercy Hospital Prebys Cancer Center, San Diego

Vključevanje udeležencevFaza 2

Starost 18–99 · Ženske · Posodobljeno 15. sep. 2026 · NCT07023627

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

City of Hope Medical Center, Duarte
Providence Medical Foundation, Fullerton
University of California, San Diego-Moores Cancer Center, La Jolla
in še 3

Vključevanje udeležencevFaza 3

Starost 18 in več · Ženske · Posodobljeno 15. sep. 2026 · NCT07214779

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

UC San Diego Health, La Jolla
Cedars Sinai Medical Center, Los Angeles

Vključevanje udeležencevFaza 2

Starost 18 in več · Ženske · Posodobljeno 14. sep. 2026 · NCT06787612

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

University of California, San Diego, La Jolla
Hoag Memorial Hospital Presbyterian, Newport Beach
Redwood City, Redwood City

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05059444

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Santa Monica
Research Site, Santa Rosa

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT05123482

Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors

Stanford University, Palo Alto

Vključevanje udeležencevFaza 1

Starost 18 in več · Ženske · Posodobljeno 10. sep. 2026 · NCT06646627

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

City of Hope, Duarte
START - Los Angeles, Los Angeles
Cedars Sinai, Los Angeles
in še 1

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT06293898

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT06400472

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

UCSF Medical Center at Mission Bay ( Site 0013), San Francisco
John Muir Health Cancer Center ( Site 0016), Walnut Creek

Vključevanje udeležencevFaza 3

Starost 18 in več · Ženske · Posodobljeno 3. sep. 2026 · NCT06824467

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

UC San Diego Moores Cancer Center, La Jolla
University of Southern California, Los Angeles

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07216105

The Vanguard Study: Testing a New Way to Screen for Cancer

Kaiser Permanente-Division of Research, Pleasanton

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 45–75 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06995898

Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer

Start Cal, Los Angeles

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Ženske · Posodobljeno 1. sep. 2026 · NCT07736937

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

University of Southern California, Los Angeles
Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
Cedars-Sanai Medical Center, Los Angeles
in še 1

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT06582017

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

City of Hope, Duarte
UC San Diego Health - Moores Cancer Center, La Jolla
Hoag Gynecologic Oncology, Newport Beach
in še 1

Vključevanje udeležencevFaza 3

Starost 18 in več · Ženske · Posodobljeno 26. avg. 2026 · NCT05281471

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

City of Hope Medical Center, Duarte

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT04329494

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

City of Hope, Duarte
Stanford, Palo Alto
University of California, San Francisco

Vključevanje udeležencevFaza 1

Starost 15 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT06276491

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.